Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.

Alexandra Bach-Weidmuller, Head of Program and Project Management at NIBR, describes her path to leadership as lateral instead of upward.

Physician-scientist Cyndy Grosskreutz explains why she transitioned from academia to industry.

Cardiovascular researcher Jennifer Allport-Anderson describes the personal qualities and decisions that have made her a successful leader.

Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Genome editing advances drug discovery in biomedical research.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.